IAVI Report

IAVI Report is a scientific publication that provides comprehensive and editorially independent coverage of HIV vaccine and prevention research, as well as the quest to develop vaccines and other preventive technologies to address other global health priorities. It features the voices and opinions of those leading these efforts and provides an unparalleled analysis of the latest scientific and policy research.

To access archived issues of IAVI Report dating back to 1996, click here.

Subscribe below to receive IAVI Report right to your inbox.

Questions/comments? Email us at iavireport@iavi.org.

Filter by

  • Health area

  • Locations

  • Topic

  • Year

  • Journal

  • Clear all

IAVI Report

“She was the best of us”

November 22, 2019

Remembering Bonnie Mathieson: A champion of young scientists

Read more

IAVI Report

Remembering David Cooper: A Great Leader in HIV Epidemiology, Treatment, and Prevention

November 22, 2019

The battle against HIV/AIDS lost another great soldier recently with the passing of Australian immunologist and clinician David Cooper on March 18. Cooper was a pioneering scientist and champion for HIV treatment and prevention, and he left an indelible mark on the field he dedicated his career to. “He had a great skill in knowing…

Read more

IAVI Report

Drawing Lessons from AIDS to Prevent Future Epidemics

November 22, 2019

Jonathan Quick describes how the right mix of science, funding, leadership, and communication can come together to secure the world against future epidemics.

Read more

IAVI Report

A Mean Flu Season Swings a Spotlight on Vaccines

November 22, 2019

Influenza, like HIV, is a highly variable menace. A particularly bad flu season has researchers seeking ways to make a better vaccine, and in doing so, there may be lessons from, and for, HIV vaccine research.

Read more

IAVI Report

Applying Innovative Approaches and Technologies to HIV Prevention

November 22, 2019

Several areas of progress in using antibodies for HIV prevention were showcased at the recent Keystone Symposia.

Read more

IAVI Report

HIV vaccine efforts herald a new era of vaccinology

November 22, 2019

We are at a defining moment in the history of HIV vaccine research. It is not an exaggeration to also propose that, thanks to the fruits of decades of HIV vaccine research and development efforts, we are entering a new era of vaccinology more broadly. A new generation of HIV vaccine candidates is poised to…

Read more

IAVI Report

A fast track for vaccine development

November 22, 2019

Coalition awards US$174 million in grants for research targeting Nipah virus, Lassa fever, and MERS.

Read more

IAVI Report

Remembering Adel Mahmoud, a giant in the vaccine world

November 22, 2019

The vaccine world lost another of its great leaders recently with the passing of Adel Mahmoud, a physician, scientist, and professor who played a critical role in the development of many innovative and lifesaving vaccines during his long and successful career. He is remembered by his friends and colleagues as a tireless champion of public…

Read more

IAVI Report

Could overly optimistic messages be contributing to the drop in global HIV/AIDS spending?

November 22, 2019

The pandemic isn’t over, but that might be what donors are hearing.

Read more

IAVI Report

IAVI REPORT – VOL. 22, NO. 2, 2018

November 22, 2019

In a few weeks, the AIDS 2018 meeting will kick off in Amsterdam. It will be the 22nd annual conference, and remains the largest international gathering focused on a single public health issue. This year, one message that will come out loud and clear is that more than 30 years later, AIDS isn’t over. As…

Read more

IAVI Report

Stopping HIV where it starts

November 22, 2019

Marianne Mureithi is part of a team of researchers that just received highly competitive funding to study mucosal immune responses to HIV in Kenya.

Read more

IAVI Report

Could vaccines reach remote areas … remotely?

November 22, 2019

Drone delivery may help overcome the challenge of getting medicines and vaccines to hard-to-reach populations.

Read more